Oral Candidiasis among Cancer Patients Attending a Tertiary Care Hospital in Chennai, South India: An Evaluation of Clinicomycological Association and Antifungal Susceptibility Pattern

Table 5

Antifungal susceptibility pattern by Microbroth dilution method.

S. number	Antifungal drug	Fluconazole resistant	Fluconazole SDD	Itraconazole resistant	Itraconazole SDD	Amphotericin B susceptible
	MIC range	>8 µg/mL	16–32 µg/mL	>0.125 µg/mL	0.25–0.5 µg/mL	<1 µg/mL
1	Candida albicans	6 (5.8%)	23 (24.4%)	12 (12.7%)	20 (21.27%)	94 (100%)
2	Candida tropicalis	4 (11.7%)	10 (29.4%)	4 (12%)	11 (32.3%)	34 (100%)
3	Candida glabrata	3 (21.4%)	4 (28.5%)	4 (28.5%)	5 (35.7%)	14 (100%)
4	Candida krusei	10 (100%)	0	4 (60%)	2 (20%)	10 (100%)
5	Candida parapsilosis	0	0	0	0	6 (100%)
6	Candida kefyr	0	0	0	0	4 (100%)
	Overall resistance%	23 (14.1%)	37 (22.8%)	22 (14.8%)	38 (23.4%)	Nil

SDD: susceptible dose dependent.
MIC: minimum inhibitory concentration.